Publication | Closed Access

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

Sleep MedicineSleep1-Year TreatmentPlacebo-controlled TrialPharmacotherapySurgerySleep ApneaInsomniaAnesthesiaMedicinePhase 3Anesthesiology